OR WAIT 15 SECS
Adroit Science AB will support Recipharm’s pharmaceutical development with solid-state characterization services.
Recipharm AB and Adroit Science AB have formed a new strategic collaboration to expand their service offering. Adroit Science AB will support Recipharm’s pharmaceutical development with solid-state characterization services. The combination of both companies’ expertise in formulation development, API development, chemical analysis, and solid-state characterization, will improve speed and reduce development costs, while improving quality.
Carl-Johan Spak, executive vice-president, Development & Technology at Recipharm, commented in a press release that the addition of development services from Adroit provides a competitive offering that will help customers to progress their projects more efficiently, including complete development from molecule to product. Adroit Science AB has established itself as a provider of solid-state characterization services in Northern Europe.
According to Hans Gredeby, CEO of Adroit Science AB, Adroit Science and Recipharm have already cooperated in a number of projects and this partnership marks the next step in the mutual development of both companies’ relationship.